The present invention relates to optionally substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds as monoamine receptor modulators; compositions comprising the same; methods of inhibiting an activity of a monoamine receptor with said compounds; methods of treating a disease condition associated with a monoamine receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.

 
Web www.patentalert.com

< Benzamides and related inhibitors of factor Xa

< Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides

> Use of pyrrolopyridine compounds for activating PPAR receptors and treatment of conditions involving such receptors

> N-linked heterocyclic antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions

~ 00611